Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Assess the Comparative Bioavailability and Pharmacokinetics of Naproxen From OXP005 Tablets (Test) And Naprosyn® Tablets (Reference) in Normal, Healthy, Adult Subjects

NCT02351024 is registered in ClinicalTrials.gov with Oxford Pharmascience Ltd as lead sponsor.

NCT NCT02351024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Assess the Comparative Bioavailability and Pharmacokinetics of Naproxen From OXP005 Tablets (Test) And Naprosyn® Tablets (Reference) in Normal, Healthy, Adult Subjects
Lead sponsor
Oxford Pharmascience Ltd
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2015
Completion date
March 31, 2015
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics